You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 94 23 486 or email: subscribe@krixos.com |
|
Most viewed
- 1. Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Cancer at ESMO 2026
- 2. Tampa General Hospital and Health Care District of Palm Beach County to Open Lakeside Cancer Center in September 2027, Expanding Access to Academic-Based Cancer Care in Florida's Rural Communities
- 3. ESMO 2026: Perioperative apalutamide in high-risk localised or locally advanced prostate cancer substudy supports reduced risk of metastasis and death
- 4. Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer
- 5. Association of Plasma CCDC88A Expression Combined with Erythrocyte Sedimentation Rate with Rheumatoid Arthritis Disease Activity: A Cross-Sectional Exploratory Study
- 6. Florida Cancer Specialists & Research Institute Drug Development Research Featured at ESMO Congress 2026
- 7. AI breast cancer survival model built by University of Cincinnati Cancer Center team could provide improved accuracy and more personalized care
- 8. "Health Is Wealth": Unicoin Foundation Launches Crypto for Good Breast Cancer Campaign
- 9. Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
- 10. Vanessa Trump 'finally cancer-free,' she says after health battle in emotional video with daughter Kai
Last updated at 16:52 GMT
